The level of human immunodeficiency virus (HIV) type 1 RNA in cerebrospinal fluid as a marker of HIV encephalitis

Clinical Infectious Diseases

Volumn 26, Issue 5, 1998, Pages 1072-1075

  Bossi, Philippe ^a   Dupin, Nicolas ^a   Coutellier, Anne ^a   Bricaire, François ^a   Lubetzki, Catherine ^a   Katlama, Christine ^a   Calvez, Vincent ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ADULT; ARTICLE; BLOOD LEVEL; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID LEVEL; COGNITIVE DEFECT; FEMALE; FEVER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEIZURE; VIRUS ENCEPHALITIS;

EID: 0031948258     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/520301     Document Type: Article

References (11)

1. Mellors IW, Rinaldo CR, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272:1167-70.
2. Coombs RW, Welles SL, Hooper C, et al. Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection. J Infect Dis 1996;174:704-12.
3. Simpson D, Tagliati M. Neurologic manifestations of HIV infection. Ann Intern Med 1994;121:769-85.
4. Price RW. Neurological complications of HIV infection. Lancet 1996;348:445-52.
5. Schmid P, Conrad A, Syndulko K, et al. Quantifying HIV-1 proviral DNA using the polymerase chain reaction on cerebrospinal fluid and blood of seropositive individuals with and without neurological abnormalities. J Acquir Immune Defic Syndr 1994;7:777-8.
6. Shaunak S, Albright RE, Klotman ME, Henry SC, Bartlett JA, Hamilton JD. Amplification of HIV-1 provirus from cerebrospinal fluid and its correlation with neurologic disease. J Infect Dis 1990;161:1068-72.
7. Brew BJ, Pemberton L, Cunningham P, Law MG. Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage. J Infect Dis 1997;175:963-6.
8. McClemon DR, Lanier ER, Nance-Sproson T, Zimmerman A, McArthur JC, St Clair MH. Quantification of HIV RNA in brain tissue, CSF and plasma: relationship to HIV-neurological disease and AZT resistance [abstract no i7]. In: Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (Toronto). Washington, DC: American Society for Microbiology, 1997.
9. Conrad AJ, Schmid P, Syndulko K, et al. Quantifying HIV-1 RNA using the polymerase chain reaction on cerebrospinal fluid and serum of seropositive individuals with and without neurologic abnormalities. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10:425-35.
10. Burger D, Boucher C, Meenhorst P, et al. HIV-1 RNA levels in the cerebrospinal fluid may increase owing the damage to the blood-brain barrier. Antiviral Therapy 1997;2:113-7.
11. Chiodi F, Keys B, Albert J, et al. Human immunodeficiency virus type-1 is present in the cerebrospinal fluid of a majority of infected individuals. J Clin Microbiol 1992;30:1768-71.